New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009, China.
New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009, China; Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
J Ethnopharmacol. 2022 Sep 15;295:115422. doi: 10.1016/j.jep.2022.115422. Epub 2022 May 30.
Triptolide (TP) is a major active ingredient and toxic component of Tripterygium wilfordii Hook F (TWHF), which exhibits multiple activities and remarkable hepatotoxicity, the latter of which limits its clinical application due to the risk of liver injury. Previous research has revealed the hepatotoxicity of TP resulting in liver hypersensitivity upon lipopolysaccharide (LPS) stimulation. However, existing research has not elucidated the potential immune mechanism such as Th17/Treg imbalance in TP-induced hepatic excessive immune response to exogenous LPS.
To investigate the role of Th17/Treg imbalance in TP-induced hepatic excessive immune response to exogenous LPS.
Mice were administered with TP, LPS, neutralization antibody and small molecule inhibitor respectively. Serum transaminase level was measured to determine the severity of liver injury. Frequencies of liver Th17 and Treg cells were analyzed by flow cytometry. Serum cytokine levels were performed by ELSIA, and mRNA levels of liver cytokine were performed by qPCR. The status of neutrophil infiltration was performed by myeloperoxidase (MPO) IHC measurement. Morphological observation of liver was performed by hematoxylin and eosin (H&E) staining.
Mice given a single intragastric dose of TP (500 μg/kg) developed lethal fulminant hepatitis following intraperitoneal injection of LPS (0.1 mg/kg), characterized by low survival rate, severe liver injury, high levels of inflammation and neutrophil infiltration. Hepatic Th17/Treg imbalance emerged together with liver injury in these mice. Neutralization of IL-17A attenuated the liver injury and ameliorated the neutrophil infiltration. The TP-induced alteration of hepatic Th17/Treg balance was closely related to the outcome of immune-mediated acute liver injury triggered by LPS. Pretreatment with the STAT3 inhibitor AG490 effectively restored Th17/Treg balance, significantly reducing the production of IL-17A and finally attenuating the degree of liver injury.
Hepatic Th17/Treg imbalance not only exacerbates TP- and LPS-induced liver injury, but also serves as an indispensable part in the mechanisms of TP-induced hepatic intolerance to exogenous endotoxin.
雷公藤内酯醇(TP)是雷公藤(TWHF)的主要活性成分和有毒成分,具有多种活性和显著的肝毒性,后者由于肝损伤的风险限制了其临床应用。先前的研究表明,TP 导致脂多糖(LPS)刺激后的肝脏过敏。然而,现有的研究尚未阐明 TP 诱导的肝脏对外源 LPS 过度免疫反应中的潜在免疫机制,如 Th17/Treg 失衡。
研究 Th17/Treg 失衡在 TP 诱导的肝脏对外源 LPS 过度免疫反应中的作用。
分别给予小鼠 TP、LPS、中和抗体和小分子抑制剂。通过测量血清转氨酶水平来确定肝损伤的严重程度。通过流式细胞术分析肝 Th17 和 Treg 细胞的频率。通过 ELSIA 检测血清细胞因子水平,通过 qPCR 检测肝细胞因子的 mRNA 水平。通过髓过氧化物酶(MPO)免疫组化测量中性粒细胞浸润的状态。通过苏木精和伊红(H&E)染色进行肝形态学观察。
单次给予 500μg/kg 的 TP 后,小鼠经腹腔注射 LPS(0.1mg/kg)后发生致命性暴发性肝炎,其特征为低存活率、严重肝损伤、高水平炎症和中性粒细胞浸润。这些小鼠的肝 Th17/Treg 失衡与肝损伤同时出现。中和 IL-17A 可减轻肝损伤并改善中性粒细胞浸润。TP 诱导的肝 Th17/Treg 平衡改变与 LPS 触发的免疫介导的急性肝损伤的结果密切相关。STAT3 抑制剂 AG490 的预处理可有效恢复 Th17/Treg 平衡,显著减少 IL-17A 的产生,最终减轻肝损伤程度。
肝 Th17/Treg 失衡不仅加重了 TP 和 LPS 诱导的肝损伤,而且还是 TP 诱导的肝脏对外源内毒素不耐受机制中的不可或缺的部分。